Therapeutic adherence of patients with breast and prostate cancers

Keywords: Breast Neoplasms; Prostatic Neoplasms; Treatment Adherence and Compliance; Oncology Nursing.

Abstract

Objective: to analyze the treatment compliance of patients with breast and prostate cancers. Methods: cross-sectional study with 303 patients with breast and prostate cancers. A semi-structured instrument and the Adherence Determinants Questionnaire Scale Brazilian version were used, and the data were analyzed using descriptive and inferential statistics. Results: mean adherence was found among all participants (100.0%). In patients with prostate cancer, we observed weak correlations between age and interpersonal aspects of care (r=0.198; p=0.048); and between treatment time and intentions (r=-0.295; p=0.049). In breast cancer patients, there was a positive correlation between age and perceived support/severity (r=0.174; p=0.013); and between years of study and interpersonal aspects of care (r=0.145; p=0.038) and intentions (r=0.156; p=0.026). Conclusion: patients with breast and prostate cancers showed moderate adherence to treatment, with higher means in the Support/Severity domain and lower in the Perceived Susceptibility domain.


References

Pérez YJR, Tejada BAM, Herrera JLH. Depresión en pacientes diagnosticados con cáncer en una institución de IV nivel en Montería, Colombia. Enferm Glob. 2019; 18(56):230-41. doi: https://doi.org/10.6018/eglobal.18.4.354161

International Agency of Cancer Research. Cancer today [Internet]. 2020 [cited Mar 15, 2021]. Available from: https://gco.iarc.fr/today/home

Lima MP, Machado WL, Irigaray TQ. Predictive factors of treatment adherence in cancer outpatients. Psychooncology. 2018; 27(12):2823-8. doi: https://doi.org/10.1002/pon.4897

Macêdo LM, Cavalcante VMV, Coelho MMF, Ramos SLTC, Correia DL, Menezes TAC, et al. The perception of ostomized patients with colorectal cancer regarding their quality of life. Rev Rene; 2020; 21:e43946. doi: https://doi.org/10.15253/2175-6783.20202143946

Rocha MR, Santos SD, Moura KR, Carvalho LS, Moura IH, Silva ARV. Health literacy and adherence to drug treatment of type 2 diabetes mellitus. Esc Anna Nery. 2019; 23(2):e20180325. doi: https://dx.doi.org/10.1590/2177-9465-EAN-2018-0325

Silva AG, Azevedo C, Mata LRF, Vasques CI. Adherence of patients to oral antineoplastic therapy: influential factors. Rev Baiana Enferm. 2017; 31(1):e16428. doi: https://dx.doi.org/10.18471/rbe.v31i1.16428

Bushatsky M, Silva RA, Lima MTC, Barros MBSC, Beltrão Neto JEV, Ramos YTM. Quality of life in women with breast cancer in chemotherapeutic treatment. Ciênc Cuid Saúde. 2017; 16(3):1-7. doi:https://doi.org/10.4025/cienccuidsaude.v16i3.36094

Cunha FF, Vasconcelos EV, Silva SED, Freitas KO. Oncologic patients representations about the antineoplastic chemotherapy treatment. J Res Fundam Care Online. 2017; 9(3):840-7. doi: https://doi.org/10.9789/2175-5361.2017.v9i3.840-847

Lessa PRA, Ribeiro SG, Aquino OS, Almeida PC, Pinheiro AKB. Validation of the Adherence Determinants Questionnaire scale among women with breast and cervical cancer. Rev Latino-Am Enfermagem. 2015; 23(5):971-8. doi: https://dx.doi.org/10.1590/0104-1169.0222.2638

Lee JY, Min YH. Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer. BMC Womens Health. 2018; 18:48. doi: http://doi.org/10.1186/s12905-018-0522-3

Lourenço RA, Veras RP. Mini-Mental State Examination: psychometric characteristics in elderly outpatients. Rev Saúde Pública. 2006; 40(4):712-9. doi: http://doi.org/10.1590/S0034-89102006000500023

Yee MK, Sereika SM, Bender CM, Brufsky A, Connolly MC, Rosenzweig MQ. Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer. Cancer. 2017; 123(11):2061-9. doi: https://dx.doi.org/10.1002/cncr.30575

Amador AA, Martínez ZJ, Marrugo PA, Taron DA, Diaz MA, Paut QAE. Adherencia, satisfacción al tratamiento y calidad de vida de pacientes con cáncer de mama en el Hospital Universitario del Caribe. (Cartagena, Colombia). Pharm Care Spe [Internet]. 2016 [cited Mar 11, 2021]; 18(6):251-64. Available from: https://www.pharmcareesp.com/index.php/PharmaCARE/article/view/355/270

Jacobs JM, Ream ME, Pensak N, Nisotel LE, Fishbeins JN, MacDonald JJ, et al. Patient experiences with oral chemotherapy: adherence, symptoms, and quality of life. J Natl Compr Canc Netw. 2019; 17(3):221-8. doi: https://dx.doi.org/10.6004/jnccn.2018.7098

Calvo LEA, Sepulveda-Carrillo GJ. Care needs of cancer patients undergoing ambulatory treatment. Enferm Glob. 2017; 16(45):353-83. doi: https://dx.doi.org/10.6018/eglobal.16.1.231681

Teston EF, Fukumori EFC, Benedetti GMS, Spigolon DN, Costa MAR, Marcon SS. Feelings and difficulties experienced by cancer patients along the diagnostic and therapeutic itineraries. Esc Anna Nery. 2018; 22(4):e20180017. doi: https://doi.org/10.1590/2177-9465-ean-2018-0017

Noronha IR, Pires AS, Noronha IR, Costa CMA, Ribeiro LV, Fassarella LG. Sexualidad y subjetividad: el impacto del cáncer de próstata en la vida sexual e identidad masculina. Psicooncología. 2019; 16(2):375-85. doi: https://doi.org/10.5209/psic.65597

Jacobs JM, Pensak NA, Sporn NJ, MacDonald JJ, Lennes IT, Safren SA, et al. Treatment satisfaction and adherence to oral chemotherapy in patients with cancer. J Oncol Pract. 2017; 13(5):e474-85. doi: https://doi.org/10.1200/JOP.2016.019729

Moon Z, Moss-Morris R, Hunter MS, Carlisle S, Hughes LD. Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review. Patient Prefer Adherence. 2017; 11:305-22. doi: https://doi.org/10.2147/PPA.S126651

Braga DAO, Vasconcelos LL, Paiva CEQ, Prado RMS, Torres KBN. Qualidade de vida do idoso em tratamento oncológico. Rev Ciênc Méd Biol [Internet]. 2019 [cited Jan 11, 2021]; 18(2):249-53. Available from: https://www.rbspa.ufba.br/index.php/cmbio/article/view/15991/20177

Published
2021-05-03
Section
Research Article